Key points from article :
NovaXS Biotech develops painless needle-free injector for self-administered medications.
Founded by Berkeley researcher Alina Su, backed by investors and medical device makers.
Device uses liquid pressure to deliver biologics in 0.3 seconds.
A cloud-based platform tracks injection data for better treatment monitoring.
Initial targets are in vitro fertilization and Duchenne muscular dystrophy (DMD) gene therapy.
Focuses on diseases requiring frequent in-home injections, like diabetes and growth hormone disorders.
Plans to secure FDA approval, build team, and conduct DMD trials in China.
